Innovent's 2025 ESG report describes an AI+NGS wet-dry closed-loop antibody discovery platform that has been applied to multiple internal projects, shortening the antibody screening cycle and improving the efficiency of discovering high-quality candidate molecules.
Source
Company Archive pending